Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics.

@article{Pilon2018AdherencePA,
  title={Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics.},
  author={Dominic Pilon and Matthew Alcusky and Yongling Xiao and Philippe Thompson-Leduc and M Lafeuille and Patrick Lefebvre and Carmela Janagap Benson},
  journal={Journal of medical economics},
  year={2018},
  volume={21 2},
  pages={135-143}
}
AIMS This study compared healthcare resource utilization (HRU), healthcare costs, adherence, and persistence among adult patients with schizophrenia using once-monthly (OM) vs twice-monthly (TM) atypical long-acting injectable (LAI) antipsychotic (AP) therapy. MATERIALS AND METHODS A longitudinal retrospective cohort study was conducted using Medicaid… CONTINUE READING